Erratum: Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority tria (The Lancet (2016) 388(10061) (2743–2752) (S0140673616320529) (10.1016/S0140-6736(16)32052-9));Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

The Lancet

Volumn 388, Issue 10061, 2016, Pages 2743-2752

  Mäkikallio, Timo ^a   Holm, Niels R ^b   Lindsay, Mitchell ^c   Spence, Mark S ^d   Erglis, Andrejs ^e   Menown, Ian B A ^f   Trovik, Thor ^g   Eskola, Markku ^h   Romppanen, Hannu ⁱ   Kellerth, Thomas ^j   Ravkilde, Jan ^k   Jensen, Lisette O ^l   Kalinauskas, Gintaras ^m   Linder, Rikard B A ⁿ   Pentikainen, Markku ^o   Hervold, Anders ^p   Banning, Adrian ^q   Zaman, Azfar ^r   Cotton, Jamen ^s   Eriksen, Erlend ^t   Margus, Sulev ^u   Sørensen, Henrik T ^b,v   Nielsen, Per H ^b   Niemelä, Matti ^a   Kervinen, Kari ^a   Lassen, Jens F ^b   Maeng, Michael ^b   Oldroyd, Keith ^c   Berg, Geoff ^c   Walsh, Simon J ^d   Hanratty, Colm G ^d   Kumsars, Indulis ^e   Stradins, Peteris ^e   Steigen, Terje K ^g   Fröbert, Ole ^j   Graham, Alastair N J ^d   Endresen, Petter C ^g   Corbascio, Matthias ^w   Kajander, Olli ^h   Trivedi, Uday ^x   Hartikainen, Juha ⁱ   Anttila, Vesa ^a   Hildick Smith, David ^x   Thuesen, Leif ^k   Christiansen, Evald H ^b   more..

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^d ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^e PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^f Craigavon Cardiac Centre   (Ireland)

^g UNIVERSITY OF TROMSØ   (Norway)

^h TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁱ KUOPIO UNIVERSITY HOSPITAL   (Finland)

^j ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^k AALBORG UNIVERSITY HOSPITAL   (Denmark)

^l ODENSE UNIVERSITY HOSPITAL   (Denmark)

^m VILNIUS UNIVERSITY   (Lithuania)

ⁿ DANDERYD HOSPITAL   (Sweden)

^o HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^p OSLO UNIVERSITY HOSPITAL   (Norway)

^q Oxford Heart Centre   (United Kingdom)

^r NEWCASTLE UNIVERSITY   (United Kingdom)

^s NEW CROSS HOSPITAL   (United Kingdom)

^t HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^u Tallinn Central Hospital   (Estonia)

^v STANFORD UNIVERSITY   (United States)

^w KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^x Brighton and Sussex University Hospitals   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERY OCCLUSION; ARTERY TRANSPLANTATION; ARTICLE; BLOOD TRANSFUSION; BONE INFECTION; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; STABLE ANGINA PECTORIS; STERNUM; SYNTAX SCORE; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EUROPE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; STANDARDS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; EUROPE; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; STROKE; TREATMENT OUTCOME;

EID: 85003691664     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)32112-2     Document Type: Erratum

References (30)

1. 1 Buszman, PE, Kiesz, SR, Bochenek, A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularisation. J Am Coll Cardiol 51 (2008), 538–545.
2. 2 Ahn, JM, Roh, JH, Kim, YH, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT Study. J Am Coll Cardiol 65 (2015), 2198–2206.
3. 3 Boudriot, E, Thiele, H, Walther, T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol 57 (2011), 538–545.
4. 4 Mohr, FW, Morice, MC, Kappetein, AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381 (2013), 629–638.
5. 5 Chieffo, A, Stankovic, G, Bonizzoni, E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005), 791–795.
6. 6 Park, SJ, Kim, YH, Lee, BK, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005), 351–356.
7. 7 Shiomi, H, Morimoto, T, Furukawa, Y, et al. Comparison of percutaneous coronary intervention with coronary artery bypass grafting in unprotected left main coronary artery disease—5-year outcome from CREDO-Kyoto PCI/CABG registry cohort–2. Circ J 79 (2015), 1282–1289.
8. 8 Valgimigli, M, van Mieghem, CA, Ong, AT, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin–Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T–SEARCH). Circulation 111 (2005), 1383–1389.
9. 9 Jang, JS, Choi, KN, Jin, HY, et al. Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease. Am J Cardiol 110 (2012), 1411–1418.
10. 10 Task Force Members, Montalescot, G, Sechtem, U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34 (2013), 2949–3003.
11. 11 Serruys, PW, Morice, MC, Kappetein, AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009), 961–972.
12. 12 Morice, MC, Serruys, PW, Kappetein, AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial. Circulation 121 (2010), 2645–2653.
13. 13 Sianos, G, Morel, MA, Kappetein, AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1 (2005), 219–227.
14. 14 Thygesen, K, Alpert, JS, Jaffe, AS, et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035.
15. 15 Campos, CM, Christiansen, EH, Stone, GW, Serruys, PW, The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation. EuroIntervention 11:suppl V (2015), V115–V119.
16. 16 Morice, MC, Serruys, PW, Kappetein, AP, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation 129 (2014), 2388–2394.
17. 17 Cavalcante, R, Sotomi, Y, Lee, CW, et al. Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease. J Am Coll Cardiol 68 (2016), 999–1009.
18. 18 Serruys, PW, Onuma, Y, Garg, S, et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularisation Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55 (2010), 1093–1101.
19. 19 Nakamura, S, Hall, P, Gaglione, A, et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol 29 (1997), 21–27.
20. 20 Park, SJ, Kim, YH, Park, DW, et al. Impact of intravascular ultrasound guidance on long–term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2 (2009), 167–177.
21. 21 Pyxaras, SA, Hunziker, L, Chieffo, A, et al. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. EuroIntervention 12 (2016), e623–e631.
22. 22 Morice, MC, Serruys, PW, Sousa, JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularisation. N Engl J Med 346 (2002), 1773–1780.
23. 23 Goldman, S, Zadina, K, Moritz, T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 44 (2004), 2149–2156.
24. 24 Campeau, L, Enjalbert, M, Lesperance, J, Bourassa, MG, Kwiterovich, P Jr, Wacholder, S, Sniderman, A, The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 311 (1984), 1329–1332.
25. 25 Chen, SL, Xu, B, Han, YL, et al. Clinical outcome after DK crush versus culotte stenting of distal left main bifurcation lesions: the 3–year follow–up results of the DKCRUSH–III Study. JACC Cardiovasc Interv 8 (2015), 1335–1342.
26. 26 Kang, SJ, Ahn, JM, Song, H, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv 4 (2011), 562–569.
27. 27 Shand, JA, Sharma, D, Hanratty, C, et al. A prospective intravascular ultrasound investigation of the necessity for and efficacy of postdilation beyond nominal diameter of 3 current generation DES platforms for the percutaneous treatment of the left main coronary artery. Catheter Cardiovasc Interv 84 (2014), 351–358.
28. 28 Foin, N, Sen, S, Allegria, E, et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations?. EuroIntervention 8 (2013), 1315–1325.
29. 29 Serruys, PW, Farooq, V, Kalesan, B, et al. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. JACC Cardiovasc Interv 6 (2013), 777–789.
30. 30 Raungaard, B, Jensen, LO, Tilsted, HH, et al. Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial. Lancet 385 (2015), 1527–1535.